W2A-10092-25043
2 vaccinations
5 coded responses
25 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 457 / OH
- Registered
- 2021-09-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-17
Registered in v-safe
-
2021-09-17
Dose 1 — Pfizer-BioNTech
- 2021-09-17
-
2021-09-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-09-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-09-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-09-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-09-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-09-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-09-24
-
2021-10-01
Survey response — day 14, dose 1MedDRA: Asthenia, Diarrhoea, Fatigue, Headache, Pain — Feeling: Fair · Be unable to work or attend schoolFree text: Fatigue, weakness, headache, body aches, and diarrhea.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Dose 2 — Pfizer-BioNTech
-
2021-10-08
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-10-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-10-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, NauseaAdult check-in
-
2021-10-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-15
- 2021-10-23
- 2021-10-31
- 2021-11-05
-
2021-11-14
Survey response — day 35, dose 2MedDRA: Ear pain, Fatigue, Headache, Oropharyngeal pain, Pain, Rhinorrhoea, Sputum discoloured — Feeling: PoorFree text: Runny nose, yellow mucus, sore throat, headache, body aches, fatigue, ear ache.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-19
Survey response — day 42, dose 2MedDRA: Ear pain, Fatigue, Headache, Lymphadenopathy, Pain, Paranasal sinus hypersecretion, Sputum discoloured — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, earache, swollen glands, yellow mucus, sinus drainage, fatigue, and body aches.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Survey response — 3 months, dose 2MedDRA: Bronchitis, Ear infection, SARS-CoV-2 test negative, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus infection, double ear infection, and bronchitis. Treated with antibiotic, tested for COVID-19 and was negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-10
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-14
-
2022-10-08
Survey response — 12 months, dose 2MedDRA: Asthma, COVID-19, Pneumonia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: COVID positive 7/10/22 followed by pneumonia Rebound of COVID 9/7/22 Diagnosed with COVID induced AsthmaMedDRA releases: 2024-11 · check-in free text available
-
2022-10-08
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-17 | Pfizer-BioNTech | No |
| 2 | 2021-10-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-07 | Successful 2022-01-10 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-10-08 | Unsuccessful |
Free text
Release 9 — day 14, dose 1
Symptoms: Fatigue, weakness, headache, body aches, and diarrhea.
Release 10 — day 35, dose 2
Symptoms: Runny nose, yellow mucus, sore throat, headache, body aches, fatigue, ear ache.
Release 10 — day 42, dose 2
Symptoms: Headache, earache, swollen glands, yellow mucus, sinus drainage, fatigue, and body aches.
Release 10 — 3 months, dose 2
Symptoms: Sinus infection, double ear infection, and bronchitis. Treated with antibiotic, tested for COVID-19 and was negative.
Release 12 — 12 months, dose 2
Symptoms: COVID positive 7/10/22 followed by pneumonia Rebound of COVID 9/7/22 Diagnosed with COVID induced Asthma
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Sputum discoloured | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release